期刊文献+

骨科围手术期抗菌药物预防感染的药物经济学分析 被引量:4

Pharmacoeconomic Analysis of Commonly Used Antibiotics to Prevent Perioperative Infection
下载PDF
导出
摘要 目的:探讨应用4种常用抗菌药物预防围手术期感染的经济效果,以寻求一种费用较低、效果显著的治疗方案。方法:回顾性调查2008年10~11月份骨科手术预防感染400份病历,进行了合理性评价,并对其使用频率高、常用的头孢硫脒、头孢替唑钠、头孢呋辛钠、头孢他啶4种抗菌药物共268份病历,运用药物经济学的成本-效果分析方法进行评价。结果:4种用药方案,头孢呋辛钠是最佳用药选择。结论:头孢呋辛钠预防围手术期感染具有成本效果优势,可作为选择治疗方案时参考。 Objective: To investigate the economic effectiveness of four antibiotics to prevent post-operation infections and find a low-cost, effective treatment options. Methods: In reviewing and investigating 400 cases for preventing infection in Orthopedics opetation from October to November,2008, we made a rational evaluation and analyzed 268 cases applied with four kinds of antimicrobial drugs of cefathiamidine, ceftezole sodium, cefuroxime sodium and ceftazidime which are frequently and commonly used by cost-effectiveness analysis in pharmacoeconomics. Results: Among those four kinds of schemes, cefuroxime sodium is the optimal option. Conclusion: Cefuroxime sodium in perioperative prevention of infection has a cost-effectiveness advantage and can be used as reference.
出处 《中国执业药师》 CAS 2009年第10期33-36,共4页 China Licensed Pharmacist
基金 2007年江门市第三批科技计划项目 编号:02
关键词 药物经济学 成本-效果分析 预防围手术期感染 抗菌药物 Pharmacoeconomics Cost - effectiveness analysis Perioperative Prevention of Infection Antimicrobial Agents
  • 相关文献

参考文献4

二级参考文献10

共引文献372

同被引文献43

  • 1李茵,于高路.左氧氟沙量不同服法预防骨关节创伤及内固定术后感染的药物经济学比较[J].海峡药学,2006,18(1):151-152. 被引量:2
  • 2周月红,张继明.骨科围手术期抗菌药物预防使用的调查[J].中华医院感染学杂志,2006,16(10):1154-1156. 被引量:21
  • 3孙惠娟,孙艳,张卫同,陈柏清.常用抗菌药物预防手术感染的药物经济学分析[J].中国药业,2007,16(11):33-34. 被引量:12
  • 4De Bleser L, Depreitere R, De Waele K, et al. Defining pathways[J]. JNurs Manag, 2006,14(7) : 553.
  • 5Bhavnani SM,Ambrose PG.Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treat-ment of hospitalized patients with community-acquired pneumonia[J].Diagnost Microb Infec Dis,2008,60(1):59-64.
  • 6Zhou QT,Zhu H.Potential for cost-Savings in the care of hospitalized low-risk community-acquired pneumonia pa-tients in China[J].Value Health,2009,12(1):40-46.
  • 7De Cock E,Sorensen S,Levrat F,et al.Cost-effective-ness of linezolid versus vancomycin for hospitalized pa-tients with complicated skin and soft-tissue infections in France[J].Med Maladies Infect,2009,39(5):330-340.
  • 8Hsueh PR,Liu CY,Shi ZY,et al.Cost minimisation anal-ysis of antimicrobial treatment for intra-abdominal infec-tions:a multicentre retrospective study from Taiwan[J].Int J Antimicrob AG,2010,35(1):94-96.
  • 9Nathwani D.Impact of methicillin-resistant Staphylococ-cus aureus infections on key health economic outcomes:does reducing the length of hospital stay matter[J].J Anti-microb Chemoth,2003,51(Suppl S2):ii37-ii44.
  • 10Alam Fasihul M,Cohen D,Butler C,et al.The additional costs of antibiotics and re-consultations for antibiotic-re-sistant Escherichia coli urinary tract infections managed in general practice[J].Int J Antimicrob AG,2009,33(3):255-257.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部